Effect of Gambogic acid on the regulation of hERG channel in K562 cells in vitro

Abstract

Overexpression of human ether-à-go-go (eag) related gene (hERG) has been found in a broad range of human leukemia cell lines and primary human leukemia. The block of hERG protein might be a potential therapeutic strategy for leukemia. Gambogic acid (GA) has recently exhibited marked anti-tumor potency on solid tumors of various derivations. Here, we investigated the anti-leukemia effects of GA and its relation to the regulation of hERG in K562 leukemia cells in vitro. K562 cells were treated with various concentrations of GA (0.125–8.0 µmol/L) for 0–72 h. MTT assay was used to evaluate the inhibition effect of GA on the growth of K562 cells. Cell apoptosis was measured through both Annexin-V FITC/PI double-labeled cytometry and transmission electron microscopy. Cell cycle regulation was studied by a propidium iodide method. RT-PCR and Western blot were applied to detect the expression level of hERG in K562 cells. GA presented striking growth inhibition and apoptosis induction potency on K562 cells in vitro in a time- and dose-dependent manner. The IC₅₀ value of GA for 24 h was 2.637±0.208 µmol/L. Moreover, GA induced K562 cells arrested in G₀/G₁ phase, accordingly, cells in S phase decreased gradually, and no obvious changes were found in G₂/M phase cells. Under the transmission electron microscopy, apoptotic bodies containing nuclear fragments were found in GA-treated K562 cells. After treatment with GA of 2.0 µmol/L for 24 h, the percentage of apoptotic cells was increased from 4.09% to 18.47% (P<0.01). Overexpression of hERG channel was found in K562 cells, while GA could down-regulate it at both protein and mRNA levels (P<0.01). It was concluded that GA exhibited its anti-leukemia effects partially through down-regulating the expression level of hERG channel in K562 cells, suggesting that GA may be a potential agent against leukemia with a mechanism of blocking hERG channel.

Keywords

gambogic acid / leukemia / hERG / apoptosis

References

[1] ArcangeliA.. Expression and role of hERG channels in cancer cells. Novartis Found Symp, 2005, 266: 225-232

[2] CrocianiO., GuastiL., BalziM., et al.. Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells. J Biol Chem, 2003, 278(5): 2947-2955

[3] LastraioliE., GuastiL., CrocianiO., et al.. herg1 gene and HERG1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells. Cancer Res, 2004, 64(2): 606-611

[4] WitchelH.J.. The HERG potassium channel as therapeutic target. Expert Opin Ther Targets, 2007, 11(3): 321-336

[5] PillozziS., BrizziM.F., BalziM., et al.. HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors. Leukemia, 2002, 16(9): 1791-1798

[6] SmithG.A.M., TsuiH.W., NewellE.W., et al.. Functional up-regulation of HERG K⁺ channels in neoplastic hematopoietic cells. J Biol Chem, 2002, 277(21): 18 528-18 534

[7] ShaoX.D., WuK.C., HaoZ.M., et al.. The potent inhibitory effects of cisapride, a specific blocker for human ether-a-go-go-related gene (HERG) channel, on gastric cancer cells. Cancer Biol Ther, 2005, 4(3): 295-301

[8] ZhaoJ., WeiX.L., JiaY.S., et al.. Silencing of herg gene by shRNA inhibits SH-SY5Y cell growth in vitro and in vivo. Euro J Pharmacol, 2008, 579(1–3): 50-57

[9] YuJ., GuoQ.L., YouQ.D., et al.. Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells. Cancer Chemother Pharmacol, 2006, 58(4): 434-443

[10] WuZ.Q., GuoQ.L., YouQ.D., et al.. Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells. Biol Pharm Bull, 2004, 27(11): 1769-1774

[11] GuoQ.L., YouQ.D., WuZ.Q., et al.. General gambogic acids inhibited growth of human hepatoma SMMC-7721 cells in vitro and in nude mice. Acta Pharmacol Sin, 2004, 25(6): 769-774

[12] WangY., ChenY., ChenZ., et al.. Gambogic acid induces death inducer-obliterator 1-mediated apoptosis in Jurkat T cells. Acta Pharmacol Sin, 2008, 29(3): 349-354

[13] ShuW.X., ChenY., HeJ., et al.. Effects of gambogic acid on the regulation of nucleoporin Nup88 in U937 cells. J Huazhong Univ Sci Technolog Med Sci, 2007, 27(4): 388-392

[14] KasibhatlaS., JessenK.A., MaliartchoukS., et al.. A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. Proc Natl Acad Sci USA, 2005, 102(34): 12 095-12 100

[15] SanguinettiM.C.. Tristani-Firouzi M. hERG potassium channels and cardiac arrhythmia. Nature, 2006, 440(7083): 463-469

[16] WangH., ZhangY. C. L., et al.. HERG K⁺ channel, a regulator of tumor cell apoptosis and proliferation. Cancer Res, 2002, 62(17): 4843-4848

[17] LinH., XiaoJ., LuoX., et al.. Overexpression of HERG K(+) channel gene mediates cell-growth signals on activation of oncoproteins SP1 and NF-kappaB and inactivation of tumor suppressor Nkx3.1. J Cell Physiol, 2007, 212(1): 137-147

[18] CherubiniA., HofmannG., PillozziS., et al.. Human ether-a-go-go-related gene 1 channels are physically linked to beta1 integrins and modulate adhesion-dependent signaling. Mol Biol Cell, 2005, 16(6): 2972-2983

[19] MasiA., BecchettiA., Restano-CassuliniR., et al.. hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines. Br J Cancer, 2005, 93(7): 781-792

[20] PillozziS., BrizziM.F., BernabeiP.A., et al.. VEGFR-1 (FLT-1), beta1 integrin, and hERG K⁺ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome. Blood, 2007, 110(4): 1238-1250

[21] ChenS.Z., ZhangS.H., GongJ.H., et al.. Erythromycin inhibits the proliferation of HERG K⁺ channel highly expressing cancer cells and shows synergy with anticancer drugs. Zhonghua Yi Xue Za Zhi (Chinese), 2006, 86(47): 3353-3357

[22] ChenS.Z., JiangM., ZhenY.S.. HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin. Cancer Chemother Pharmacol, 2005, 56(2): 212-220

[23] YuJ., GuoQ.L., YouQ.D., et al.. Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells. Carcinogenesis, 2007, 28(3): 632-638